$0.43
-0.01 (-2.91%)
Open$0.44
Previous Close$0.44
Day High$0.48
Day Low$0.42
52W High$1.82
52W Low$0.42
Volume—
Avg Volume165.7K
Market Cap44.81M
P/E Ratio—
EPS$-5.52
SectorN/A
Analyst Ratings
Buy
9 analysts
Price Target
+813.7% upside
Current
$0.43
$0.43
Target
$3.93
$3.93
$2.76
$3.93 avg
$6.09
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 1.45B | 1.32B | 17.89M |
| Net Income | -575,610,096 | -473,363,565 | 2.66M |
| Profit Margin | -39.8% | -37.8% | 14.8% |
| EBITDA | -432,584,980 | -375,507,795 | 4.50M |
| Free Cash Flow | — | — | 2.54M |
| Rev Growth | +9.4% | +9.4% | -6.4% |
| Debt/Equity | 6.52 | 6.52 | 0.53 |
N/A Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| EMAT | Evolution Metals & Technolog | $3.20 | +0.00% | — | 2.01B |
| PICS | Pics Nv | $8.32 | -4.26% | 4.4 | 1.13B |
| DMII | Drugs Made In America Acquis | $10.16 | +0.10% | 49.7 | 646.56M |
| CCCX | Churchill Capital Corp X-A | $10.08 | -5.62% | — | 2.32B |
| BEAG | Bold Eagle Acquisition Cor-A | $10.76 | +0.47% | 42.2 | 335.42M |
| CEPF | Cantor Equity Partners-Cl A | $10.30 | +0.15% | 41.3 | 587.79M |